Connexion
E-mail
Mot de passe
Afficher le mot de passe
Retenir
Mot de passe oublié ?
Devenir membre gratuitement
Inscription
Inscription
Devenir membre
Inscription gratuite
Devenir client
Découvrez nos services
Paramètres
Paramètres
Cotations dynamiques 
OFFON
  1. Accueil Zonebourse
  2. Actions
  3. France
  4. Euronext Paris
  5. Innate Pharma
  6. Fonds
    IPH   FR0010331421

INNATE PHARMA

(IPH)
  Rapport
SynthèseCotationsGraphiquesActualitésNotationsAgendaSociétéFinancesConsensusRévisionsDérivésFondsCommunauté 
ETFs positionnés sur INNATE PHARMAETFs et Trackers avec Trackinsight
ETF PoidsVar. 5joursRatingGéographie
Lyxor PEA PME (DR) - Dist - EUR1.97%5.07%France
UBS ETF - MSCI EMU Small Cap A-dis - EUR0.05%1.10%Europe
Lyxor MSCI EMU Small Cap (DR) - Dist - EUR0.04%0.87%Europe
IShares MSCI Europe Small-Cap ETF - USD0.02%1.01%Europe
BMO MSCI Genomic Innovation Index ETF - CAD0.01%1.09%-NC
IShares MSCI EAFE Small-Cap ETF - USD0.01%0.96%EAFE
Xtrackers MSCI Eurozone Hedged Equity ETF ...0%0.55%Europe



Copyright © 2009 Morningstar. All Rights Reserved. The information, data and opinions expressed (“Information”) and contained herein: (1) are proprietary to Morningstar and/or its content providers and are not intended to represent investment advice or recommendation to buy or sell any security; (2) may not be copied or distributed without express license to do so; and (3) are not warranted to be accurate, complete or timely. Morningstar reserve its rights to charge for access to these Ratings and/or Rating report. Neither Morningstar nor its content providers are responsible for any damages or losses arising from any use of this Rating, Rating Report or Information contained therein.
Graphique INNATE PHARMA
Durée : Période :
Innate Pharma : Graphique analyse technique Innate Pharma | Zone bourse
Graphique plein écran
Evolution du Compte de Résultat
Consensus
Vente
Achat
Recommandation moyenne ACCUMULER
Nombre d'Analystes 3
Dernier Cours de Cloture 4,85 €
Objectif de cours Moyen 7,77 €
Ecart / Objectif Moyen 60,2%
Révisions de BNA
Secteur et Concurrence
Var. 1janvCapi. (M$)
INNATE PHARMA40.03%447
MODERNA, INC.212.57%131 807
LONZA GROUP AG32.74%61 177
IQVIA HOLDINGS INC.43.38%49 092
SEAGEN INC.-2.12%31 189
CELLTRION, INC.-38.86%25 455